middle.news
INOVIQ Raises $11.5M to Accelerate Ovarian Cancer Test and Therapeutics
9:59am on Monday 13th of October, 2025 AEDT
•
Healthcare
Read Story
INOVIQ Raises $11.5M to Accelerate Ovarian Cancer Test and Therapeutics
9:59am on Monday 13th of October, 2025 AEDT
Key Points
Raised $9.5 million via placement at $0.35 per share
Tian An Medicare commits $5 million as cornerstone investor
Share purchase plan targets $2 million from existing shareholders
Funds to accelerate clinical validation and commercialisation of EXO-OC test
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Inoviq (ASX:IIQ)
OPEN ARTICLE